Paula Miranda

Paula Miranda, PhD MBA, is a seasoned leader in gene therapy with a decade of experience in biotechnology. Their journey began with a PhD focused on gene therapy at the University of Amsterdam, where they developed innovative approaches for clinical applications. Previously, they held various roles at AMC and uniQure, where they led teams on global drug development projects and contributed to successful regulatory submissions. Currently, as the Director of Pre-Clinical Translation at VectorY, Paula remains dedicated to advancing transformative therapies for patients with high unmet medical needs.